BSE: STAR - Strides Pharma Science Limited

六个月盈利: -57.9%
股息率: +0.05%

促销时间表 Strides Pharma Science Limited


关于公司 Strides Pharma Science Limited

Strides Pharma Science Limited develops, manufactures, and sells pharmaceutical products in Africa, Australia, North America, Europe, Asia, India, and internationally. It operates through two segments, Pharmaceutical and Biopharmaceutical. The company offers pharma generics in various forms, such as tablets, hard and soft gelatin capsules, sachets, and liquids, as well as nasal spray, gels, powders, solids, ointments, and creams.

更多详情
It also develops branded generics products for the treatment of chronic therapies, including women's health, central nervous system, cardiovascular, diabetes, dermatology, and probiotics under the Renerve, Unibrol, Combiart, Duotab, and Vitafer brands; and anti-retroviral, anti-malarial, anti-tuberculosis, Hepatitis, and other infectious disease drug segments for institutional business. The company was formerly known as Strides Shasun Limited and changed its name to Strides Pharma Science Limited in July 2018. Strides Pharma Science Limited was incorporated in 1990 and is headquartered in Bengaluru, India.

ISIN INE939A01011
Industry Pharmaceuticals
Sector Health Care
Валюта inr
Валюта отчета inr
Див.доход ао 0.0512
Дивиденд ао 1.14
Сайт https://www.strides.com
Цена ао 586.05
每日价格变化: 0% (586.05)
每周价格变化: -5.67% (621.3)
每月价格变化: -11.87% (665)
3个月内价格变化: -18.24% (716.8)
六个月内的价格变化: -57.9% (1392.1)
每年价格变化: -25.74% (789.2)
3年内价格变化: +77.86% (329.5)
5年内价格变化: +26.36% (463.8)
10年价格变化: 0% (586.05)
年初以来价格变化: -14.79% (687.8)

低估

姓名 意义 年级
P/S 1.83 8
P/BV 3.44 5
P/E 0 0
EV/EBITDA 22.91 5
全部的: 5.5

效率

姓名 意义 年级
ROA, % -1.13 0
ROE, % -3.26 0
全部的: 0.6667

股息

姓名 意义 年级
Div yield, % 0.0512 0.13
DSI 0.8571 8.57
全部的: 1.79

责任

姓名 意义 年级
Debt/EBITDA 11.07 0
全部的: 5.8

成长冲动

姓名 意义 年级
盈利能力 Revenue, % 43.72 6
盈利能力 Ebitda, % -46.65 0
盈利能力 EPS, % -289.02 0
全部的: 3.2

导师 职称 支付 出生年份
Mr. Arun Kumar Pillai B.Com. Founder & Executive Chairperson 60M 1961 (64 年)
Mr. Badree Komandur MD & Group CEO 44M 1972 (53 年)
Ms. Manjula Ramamurthy Compliance Officer & Company Secretary N/A
Sormistha Ghosh Group General Counsel, Chief Risk Officer & Chief Sustainability Officer N/A
Mr. C. K. Sundar Executive Vice President of Operations N/A
Mr. Kevin P. Cook Senior Vice President of Strides Pharma Inc. N/A
Mr. P. V. S. Ramaraju Chief Operating Officer N/A
Mr. Aditya Arun Kumar Executive Director of Business Development & Director
Mr. Vikesh Kumar Group CFO & Chief Investor Relations Officer 1985 (40 年)
Ms. Surabhi Loshali Group Chief Human Resource Officer 1980 (45 年)

地址: India, Bengaluru, Strides House - 在 Google 地图中打开, 打开 Yandex 地图
网站: https://www.strides.com